Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - Mankind Pharma partners Denovo Sciences for AI-led drug discovery
Mankind Pharma partners Denovo Sciences for AI-led drug discovery
BusinessLine

Mankind Pharma Ltd on Wednesday announced a strategic collaboration with Denovo Sciences to launch an AI-led drug discovery programme. The partnership marks an important step in the company's focus on innovation-driven and technology-enabled…

theguardian.com - Andrew Gregory - US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
The Guardian

The NHS will have to divert £45bn from essential services to pay for new medicines under the terms of the UK-US trade deal agreed last December, leading to more than 200,000 avoidable deaths of patients, analysis has found. Ministers have…

sashalatypova.substack.com - Sasha Latypova - Futile, Deadly & Guaranteed to Fail: HHS and Pharma updates.
Futile, Deadly & Guaranteed to Fail: HHS and Pharma updates.
Due Diligence and Art

This post is a compilation of recent news in the field of Public Hellth before we take a short break to attend the [cheerful] memorial services for what 250 years ago was a reasonably good idea of an independent country, with Constitutional…

mirror.co.uk - Martin Bagot - NHS drug pricing deal with Donald Trump will 'cause more deaths than Covid'
NHS drug pricing deal with Donald Trump will 'cause more deaths than Covid'
Daily Mirror

Britain's drug pricing deal with Donald Trump will cause more deaths than the Covid-19 pandemic if NHS funds are diverted to pay for it, a new study predicted. A health assessment of the US trade deal showed it could lead to 229,000 deaths by 2036…

globenewswire.com - SPIE SA - SPIE acquires nimeg ag
SPIE acquires nimeg ag
GlobeNewswire

Cergy, July 1, 2026 – SPIE, the independent European leader in multi-technical services in the areas of energy infrastructure and communications, announces the acquisition of nimeg ag, a specialised engineering service provider for the life…

seekingalpha.com - Galzus Research - Daiichi Sankyo: Not Exciting Enough For This Market, Apparently (OTCMKTS:DSKYF)
Daiichi Sankyo: Not Exciting Enough For This Market, Apparently (OTCMKTS:DSKYF)
Seeking Alpha

Daiichi Sankyo maintains strong growth prospects, driven by its expanding antibody-drug conjugate (ADC) pipeline and disciplined oncology development. Trastuzumab deruxtecan remains a key growth driver, with ongoing label expansions and pivotal…

prnewswire.com - Covenant Venture Capital - Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Covenant Makes Follow-On Investment in Hill Research, Citing Fourfold Revenue Growth and Accelerating Market Adoption
Cision PR Newswire

Hill Research increased revenue approximately fourfold from 2024 to 2025. Over the same period, the company's enterprise value doubled. Heading into 2026, Hill Research is positioned to grow an additional 5 to 8 times, supported by accelerating…

thecentersquare.com - By David Beasley | The Center Square contributor - Tax system overhaul better than credits, think tank says
Tax system overhaul better than credits, think tank says
The Center Square

(The Center Square) – Instead of awarding job creation tax credits to individual companies that expand or build new businesses in Ohio, the state should focus on overhauling its entire tax code to make it more favorable to all businesses, a…

globenewswire.com - Idorsia Pharmaceuticals Ltd - Idorsia appoints Roland Wandeler as Chief Executive Officer
Idorsia appoints Roland Wandeler as Chief Executive Officer
GlobeNewswire

Ad hoc announcement pursuant to Art. 53 LR Idorsia appoints Roland Wandeler as CEO – effective October 1, 2026 – an experienced biopharmaceutical executive combining scientific expertise with business acumen to translate innovation…

fortune.com - Lily Mae Lazarus - Eli Lilly just placed a $40 million bet on the next injectable boom
Eli Lilly just placed a $40 million bet on the next injectable boom
Fortune

Eli Lilly just wrote a $40 million check to cure baldness. The pharma giant behind Zepbound and Mounjaro—which made the injectable culturally normal for millions of Americans—led a $100 million stock offering in Absci, a generative AI…

newswire.ca - Michael Goettler Resigns from Bausch Health's Board of Directors
Michael Goettler Resigns from Bausch Health's Board of Directors
CNW

LAVAL, QC, July 1, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that Michael Goettler has resigned from its Board of Directors, effective June 30, 2026, in connection with his appointment as President and Chief…

wwd.com - Martino Carrera - Camera della Moda Unveils New Study on Made in Italy as It Renews Board, Confirms Chairman
Camera della Moda Unveils New Study on Made in Italy as It Renews Board, Confirms Chairman
WWD

MILAN — Italy's fashion governing body Camera Nazionale della Moda Italiana has renewed its board for the 2026 to 2028 period, unanimously confirming chairman Carlo Capasa in his role. He was first elected in 2015. The association marked the…

mediaite.com - Zachary Leeman - 'I Say This as a True Fan': Megyn Kelly Admits She 'Can't Stand' Trump Sons' Grift
'I Say This as a True Fan': Megyn Kelly Admits She 'Can't Stand' Trump Sons' Grift
Mediaite

Megyn Kelly is a “true fan” of the Trump family, but she made it clear that doesn't mean she's okay with the family's “grifty” moves since President Donald Trump entered his second term in the White House. Kelly spoke to…

ndtv.com - Rishabh Madhavendra Pratap - Economic Security Declaration To AI: What's On Japan PM's India Agenda
Economic Security Declaration To AI: What's On Japan PM's India Agenda
NDTV

PM Takaichi has arrived in New Delhi on July 1. Summary is AI-generated, newsroom-reviewed India, Japan to release a declaration on Economic Security Cooperation after PM Modi and PM Takaichi's meeting Declaration covers critical technologies…

globenewswire.com - Santhera Pharmaceuticals Holding AG - Santhera Notes Topline Results from Catalyst Pharmaceuticals' Phase 1 Clinical Study of AGAMREE
Santhera Notes Topline Results from Catalyst Pharmaceuticals' Phase 1 Clinical Study of AGAMREE
GlobeNewswire

Data support AGAMREE's potential use as a treatment across a broad range of chronic inflammatory rare diseases Pratteln, Switzerland, July 1, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes topline results from a two-part Phase 1…

Receive a Daily briefing on Pharma Industry News

Get Started